24 related articles for article (PubMed ID: 19192657)
1. Radiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors.
Kühnöl J; Kühnöl C; Vordermark D
Oncol Lett; 2016 May; 11(5):3223-3227. PubMed ID: 27123095
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
Steinmann D; Paelecke-Habermann Y; Geinitz H; Aschoff R; Bayerl A; Bölling T; Bosch E; Bruns F; Eichenseder-Seiss U; Gerstein J; Gharbi N; Hagg J; Hipp M; Kleff I; Müller A; Schäfer C; Schleicher U; Sehlen S; Theodorou M; Wypior HJ; Zehentmayr F; van Oorschot B; Vordermark D
BMC Cancer; 2012 Jul; 12():283. PubMed ID: 22780988
[TBL] [Abstract][Full Text] [Related]
3. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
6. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
8. Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease.
Meyer A; Steinmann D; Malaimare L; Karstens JH; Bremer M
Anticancer Res; 2008; 28(6B):3965-9. PubMed ID: 19192657
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary management of brain metastases.
Eichler AF; Loeffler JS
Oncologist; 2007 Jul; 12(7):884-98. PubMed ID: 17673619
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.
Brown PD; Asher AL; Farace E
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1305-9. PubMed ID: 18234426
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy for metastatic breast cancer].
Imajo Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():484-90. PubMed ID: 17682198
[No Abstract] [Full Text] [Related]
12. Role of efaproxiral in metastatic brain tumors.
Engel RH; Kaklamani VG
Expert Rev Anticancer Ther; 2006 Apr; 6(4):477-85. PubMed ID: 16613536
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
